Today: 9 June 2026
Lucyd stock jumps 49% in premarket after sales update, insider buying plan
8 January 2026
1 min read

Lucyd stock jumps 49% in premarket after sales update, insider buying plan

New York, January 8, 2026, 05:28 EST — Premarket

Lucyd, Inc shares jumped about 49% to $1.74 in premarket trading on Thursday after the smart eyewear maker reported a rise in 2025 sales and signaled insider buying. The company said preliminary, unaudited fourth-quarter sales were about $1 million and full-year sales about $2.7 million, up about 65% from 2024; it also pegged its Amazon market share in smart safety glasses at about 44%. Chief executive Harrison Gross said he was “optimistic about our prospects for significant placements with national, well recognized chains during 2026,” and the company said any insider trades would be disclosed on Form 4, the SEC form used to report them. PR Newswire

The move lands as smart glasses draw fresh attention around CES season and wider consumer demand signals. Meta Platforms has paused a planned European rollout of its latest smart Ray-Bans after a surge in U.S. demand strained supply, the Wall Street Journal reported.

For Lucyd, the update is one of the first reads on holiday-quarter demand that investors have seen ahead of audited results. The sales base is still small, so the market tends to trade the next distribution story rather than the last quarter.

Lucyd sells Bluetooth audio smart eyewear under the Lucyd brand, including Lucyd Lyte and Lucyd Armor, and co-branded lines such as Nautica, Eddie Bauer and Reebok, its quarterly report showed. Shareholders voted in October to approve a corporate name change from Innovative Eyewear to Lucyd, Inc, an SEC filing showed.

The stock’s first test comes after the open, when thin premarket moves can either fade or turn into a broader run. Traders will be watching whether buying holds once regular-session volume shows up.

But the figures were preliminary and unaudited, and management framed the share buys as an intent rather than a commitment. The company also cautioned that timing and amounts would depend on market conditions.

Stock Market Today

  • Alibaba Stock Falls 18% Amid Heavy AI Investment
    June 9, 2026, 10:38 AM EDT. Alibaba shares have dropped 18% year-to-date, weighed down by the company's aggressive spending on artificial intelligence (AI) initiatives. This investment strategy has raised concerns among investors about its impact on short-term profitability. The stock's decline outpaces broader market trends and highlights the risks tech giants face when prioritizing long-term innovation over immediate earnings. Analysts note the move reflects Alibaba's commitment to staying competitive in the evolving technology landscape despite near-term challenges.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
City Developments stock climbs after JPMorgan lifts target, flags “strategic review”
Previous Story

City Developments stock climbs after JPMorgan lifts target, flags “strategic review”

Nvidia’s China H200 payment demand hits chip stocks premarket as Intel pops, TSMC sinks
Next Story

Nvidia’s China H200 payment demand hits chip stocks premarket as Intel pops, TSMC sinks

Go toTop